RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2
Project

Toshiba began foreign sales of a system of radiation with heavy ions. Price

Customers: Health care system at the Yonse (yonsei University Health System) university

Pharmaceutics, medicine, health care

Contractors: Toshiba


Project date: 2018/03

On March 29, 2018 the Toshiba company announced the first foreign contract in the field of the equipment for therapy by heavy ions. The Japanese vendor will deliver the Toshiba Heavy Ion Therapy CI-1000S system for treatment of oncological diseases of one of the leading South Korean clinics Yonsei University Health System (YUHS) (A health care system at the Yonse university).

At therapy by heavy ions, precisely and considerably destroying cancer cells, bunches of heavy ions (carbon ions) disperse up to 70% of light speed and are focused on a tumor.

System of radiation by heavy ions of Toshiba Heavy Ion Therapy CI-1000S

According to Nikkei, the cost of the equipment of Toshiba is about 15 billion yens ($141 million), however the edition notes that the high price of installation is justified by efficiency of a method for treatment of malignant tumors of lungs, a liver and a pancreas which badly give in to other types of radiation therapy.

Selecting between several competing products, the YUHS clinic gave preference to installation of Toshiba taking into account its compactness, an opportunity to precisely configure force of a bunch of particles and to adjust area of radiation, the representative of the South Korean side explained.

The division of Toshiba Energy Systems & Solutions will supply the necessary equipment in cooperation with the Korean medical company DK Medical Solutions. Also Toshiba expects to sign the separate contract for installation service maintenance. Treatment using the system of Toshiba for therapy by heavy ions is supposed to be begun in 2022.[1]

In 2016 Toshiba sold to the compatriot Canon business on release of the medical equipment, but saved the division of Toshiba Energy Systems occupied with nuclear technologies with which the equipment for therapy is closely connected by heavy ions. Toshiba intends to strengthen the positions on this direction, using the achievements in the field of superconducting magnets, semiconductors and nuclear energy, the vice president of the company to Mamoru Hatazawa emphasized, addressing media on March 29, 2018.[2]

Notes